Roche Products Limited v Hylebut Pty Limited

Link copied
Case Copied 24 min read

TRADE MARKS ACT 1995



DECISION OF A DELEGATE OF THE REGISTRAR OF TRADE MARKS WITH REASONS

Re:Opposition by ROCHE PRODUCTS LIMITED to registration of trade mark application 993199(25) - VALIUM AND DEVICE - filed in the name of HYLEBUT PTY LIMITED.

Delegate:

Don Nancarrow

Representation:

Opponent: Gerard Skelly, Spruson & Ferguson, Sydney.

Applicant: Caroline Ryan, DLA Phillips Fox, Brisbane.

Decision:

2007 ATMO 74

s. 52 opposition – s. 43: no connotation likely to deceive or confuse; s. 60: use of opposed trade mark likely to deceive or confuse in face of opponent’s deceptively similar trade mark with acquired reputation. Application refused. Costs – applicant to pay opponent’s costs.

Background

  1. Hylebut Pty Limited (‘the applicant’) filed application number 993199 on 16 March 2004 in class 25 of the International Classification of Goods and Services (‘Nice’ classification) in respect of ‘clothing, hats’. Other details of the application are set out below.

Trade mark:  

Acceptance advertised:          15 July 2004

  1. Roche Products Limited (‘the opponent’) filed a Notice of Opposition to the registration of this application on 15 October 2004 which nominated grounds under sections 41, 42(b), 43, 44, 58, 59, 60 and 62(b) of the Trade Marks Act 1995 (‘the Act’).  Thereafter the parties served and filed evidence (in support and answer) in accord with the provisions of the Trade Mark Regulations 1995 (‘the Regulations’) and the matter was set down to be heard on 6 February 2007.

  2. A matter of days prior to the hearing the applicant sought permission to serve further evidence in terms of Regulation 5.15. The opponent’s legal representative immediately responded that if the further evidence was admitted it wanted the opportunity to reply to this material. The hearing was cancelled and the evidence issues were addressed.

  3. In addition to both of the parties serving their further evidence, Simon Williams, for the opponent, requested and was issued with a ‘Notice Requiring Production of a Document or Article’ under section 202 of the Act which it served on the applicant. The applicant provided a response that stated that the only information in its possession on the subjects raised in the ‘Notice to Produce Documents’ could be found in the earlier declaration (25 January 2007) of Michael Anthony McIntosh and outlined some specific points. Given the end result, I must confess to being somewhat confused by the introduction of the ‘Notice to Produce’. Apparently the ultimate intention of the opponent was to gain an admission from the applicant that it was aware of the opponent’s trade mark – yet this is implicit in McIntosh 2 (see The Evidence below) at ¶7 and explicit at ¶15 – in a declaration that was already in evidence. I had anticipated that the opponent had greater reason than this when the ‘Notice to Produce’ had been requested but, in the end, it did little more than delay the proceedings.

  4. The matter was then set down, once again, to be heard on 23 August 2007 in Canberra. Gerard Skelly of Spruson & Ferguson, Sydney, appeared in…

CaseChat AU logo

Keep reading for free

Create a free CaseChat account to read Roche Products Limited v Hylebut Pty Limited and more:

  • Read every judgment in full
  • Ask AI and get answers linked to paragraphs
  • See how each paragraph was cited in later cases
  • Download judgments as PDF or Word
Continue with Google

One click creates your free account or signs you in.

By continuing you agree to the Terms and Privacy Policy.

Details
Case
[2007] ATMO 74
Decision Date

CaseChat Overview and Summary

Roche Products Limited (the applicant) sought to register a trade mark, which was opposed by Hylebut Pty Limited (the opponent). The dispute concerned the potential for the applicant's proposed trade mark to cause deception or confusion, given the opponent's established trade mark. The matter was heard by Don Nancarrow.

The court was required to determine whether the applicant's proposed trade mark was deceptively similar to the opponent's registered trade mark, VALIUM, and whether, due to the reputation of the VALIUM trade mark, the use of the applicant's trade mark would be likely to deceive or cause confusion. The court also considered the relevance of a device element in the applicant's proposed mark and the extent of the reputation of the VALIUM trade mark in the Australian market for pharmaceuticals treating anxiety and tension.

The court found that the respective trade marks were substantially identical in their word components, with only minor differences in font. The device element in the applicant's mark, depicting a relaxed person, was considered to add little to visual differentiation and, in fact, could reinforce the conceptual link to the relaxing effect of the opponent's pharmaceutical products. Applying the concept of 'contextual confusion', the court concluded that the trade marks were deceptively similar. The court acknowledged the impressive reputation of the VALIUM trade mark, supported by substantial use since 1963 and significant public recognition demonstrated through various publications. The central question then became whether the applicant's proposed use of its trade mark, given the VALIUM trade mark's reputation, would likely deceive or cause confusion.

The court found that the respective trade marks were deceptively similar and that, due to the strong reputation of the VALIUM trade mark, the use of the applicant's trade mark would be likely to deceive or cause confusion. Consequently, the opposition was successful.

Orders

Orders of the court

Full text does not contain this section.

Background

Background to the litigation

For such a visual comparison the applicant also directed my attention to the device element in the opposed trade mark as a means to differentiate the respective trade marks – but this, in my opinion, is of quite limited assistance. The actual device, shown at ¶1 the Background to these reasons, above, depicts an outline of a person either sitting or semi-reclining, in a bean bag or on an armchair in an extremely relaxed pose. On one level it adds little to enable a contrast in trade marks because there is no element in the opponent’s trade mark by which visual differentiation may be made[5]. On another level the applicant’s device adds nothing new conceptually to the opponent’s VALIUM trade mark. I take Mr. Skelly’s point that the device element may, in fact, reinforce the thought that the respective trade marks bear some relationship because the device shows a person in a very relaxed pose – an effect that the pharmaceutical goods are designed to achieve. I also note that the opponent’s trade mark and the word part (either orally or visually) of the opposed trade mark are substantially identical – the minor visual difference being the respective fonts used for the words. Given this overall background, I am led to the conclusion that the respective trade marks of the parties are deceptively similar.[5] Such a comparison brings in the concept of ‘contextual confusion’ whereby the trade marks themselves may be seen to be different, but still not be seen to identify different trade sources. (John Fitton & Co. Ltd’s Application, 66 RPC 110, at 113) On the matter of reputation at the relevant date (being the date of filing on 16 March 2004) I do not believe that the applicant contested the fact that the reputation enjoyed by the opponent’s VALIUM trade mark is impressive in relation to prescription pharmaceuticals for the treatment of anxiety and tension. The evidence overwhelmingly supports such a conclusion demonstrated by substantial use from as early as 1963 in Australia and the level of public recognition as shown in the various publications in the exhibits (McCormick & Co Inc. v McCormick 51 IPR 102 at ¶81 to ¶86, HugoBoss AG v Jackson International Trading Company 47 IPR 423 at 436). The opponent wished, however, to go beyond that level and claim that the VALIUM trade mark had attained a degree of notoriety that has reached the status of ‘famous’ or ‘notoriously familiar’ to Australian consumers. These words do not find direct application in section 60 beyond supporting that the opponent’s trade mark enjoys a very strong level of reputation. Given my findings so far under section 60, the question that remains to be decided is simply – ‘because of the reputation acquired in the VALIUM trade mark by the opponent, would use of the applicant’s trade mark in a normal and fair manner be likely to deceive or cause confusion?’ The applicant’s evidence shows that it has used a small group of similar VALIUM trade marks at its chain of fashion retail outlets (Powerhouse M&F) in New South Wales, Queensland and the Northern Territory in relation to men’s t-shirts, knitwear, jeans, shirts, belts, shorts and pants.

Evidence

Evidence Before The Court

In addition to both of the parties serving their further evidence, Simon Williams, for the opponent, requested and was issued with a ‘Notice Requiring Production of a Document or Article’ under section 202 of the Act which it served on the applicant. The applicant provided a response that stated that the only information in its possession on the subjects raised in the ‘Notice to Produce Documents’ could be found in the earlier declaration (25 January 2007) of Michael Anthony McIntosh and outlined some specific points. Given the end result, I must confess to being somewhat confused by the introduction of the ‘Notice to Produce’. Apparently the ultimate intention of the opponent was to gain an admission from the applicant that it was aware of the opponent’s trade mark – yet this is implicit in McIntosh 2 (see The Evidence below) at ¶7 and explicit at ¶15 – in a declaration that was already in evidence. I had anticipated that the opponent had greater reason than this when the ‘Notice to Produce’ had been requested but, in the end, it did little more than delay the proceedings. The matter was then set down, once again, to be heard on 23 August 2007 in Canberra. Gerard Skelly of Spruson & Ferguson, Sydney, appeared in person for the opponent and Caroline Ryan of DLA Phillips Fox, Brisbane, represented the applicant by providing submissions via a telephone link. The evidence as filed and served is set out in the table below. The evidence goes to show the considerable reputation that the opponent enjoys in its VALIUM trade mark in respect of pharmaceutical products for the treatment of anxiety and tension. The products have been available Australia-wide since 1963. Specific evidence, showing the wholesale sales figures in Australia from 1977 to 2004, verifies my own knowledge that the opponent has not only achieved a sizeable portion of the market for such pharmaceuticals but that the Australian community is well aware of the existence of the opponent’s trade mark. More than one hundred magazine and newspaper articles, dating from April 1973 to March 2004, from leading Australian publications (exhibit ‘JFH-13’) also support the level of awareness of the VALIUM trade mark in the general community that has been claimed by the opponent. Some seven articles in the same exhibit which were dated after the application date, being 16 March 2004, were also provided, but could not directly support the reputation to be assessed for this opposition action. A selection of radio and television scripts (exhibit ‘JFH-14’), various artistic works (exhibit ‘JFH-15’) and a short series of book reviews (exhibit ‘JFH-16’) also go toward demonstrating a community awareness of the VALIUM trade mark. The evidence also demonstrates that the opponent uses the trade mark in the form ‘Valium’ or, at times, as ‘VALIUM’ both in normal typescripts. Details of the opponent’s registered trade mark are in evidence (exhibit ‘VHM-1’) as is an internet search for the word ‘valium’ (exhibit ‘VHM-2’) and standard dictionary definitions (showing use as a trade mark) for the word (exhibit ‘VHM-5’).

Decision

Reasons for decision

Full text does not contain this section.

Ratio Decidendi

Legal Principle Established

Full text does not contain this section.